Aug 132020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, UT – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced the appointment of Paul J. Diaz to its Board of Directors as President and CEO effective August 13, 2020. Mr. Diaz brings to Myriad Genetics more than three decades of ...

Myriad Genetics appoints Paul Diaz to its Board of Directors as CEO

Myriad Genetics appoints Paul Diaz to its Board of Directors as CEO

From:: Myriad Genetics appoints Paul Diaz to its Board of Directors as CEO

Sorry, the comment form is closed at this time.